{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:35:49Z","timestamp":1790202949973,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent studies have revealed unique biological characteristics of molecular hydrogen (H<jats:sub>2<\/jats:sub>) as an anti-inflammatory agent. We developed a novel haemodialysis (E-HD) system delivering an H<jats:sub>2<\/jats:sub> (30\u201380 ppb)-enriched dialysis solution by water electrolysis, and conducted a non-randomized, non-blinded, prospective observational study exploring its clinical impact. Prevalent chronic HD patients were allocated to either the E-HD (n\u2009=\u2009161) group or the conventional HD (C-HD: n\u2009=\u2009148) group, and received the respective HD treatments during the study. The primary endpoint was a composite of all-cause mortality and development of non-lethal cardio-cerebrovascular events (cardiac disease, apoplexy, and leg amputation due to peripheral artery disease). During the 3.28-year mean observation period, there were no differences in dialysis parameters between the two groups; however, post-dialysis hypertension was ameliorated with significant reductions in antihypertensive agents in the E-HD patients. There were 91 events (50 in the C-HD group and 41 in the E-HD group). Multivariate analysis of the Cox proportional hazards model revealed E-HD as an independent significant factor for the primary endpoint (hazard ratio 0.59; [95% confidence interval: 0.38\u20130.92]) after adjusting for confounding factors (age, cardiovascular disease history, serum albumin, and C-reactive protein). HD applying an H<jats:sub>2<\/jats:sub>-dissolved HD solution could improve the prognosis of chronic HD patients.<\/jats:p>","DOI":"10.1038\/s41598-017-18537-x","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T10:27:52Z","timestamp":1515061672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Novel haemodialysis (HD) treatment employing molecular hydrogen (H2)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study"],"prefix":"10.1038","volume":"8","author":[{"given":"Masaaki","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritomo","family":"Itami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hodaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kabayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"18537_CR1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","volume":"55","author":"J Zimmermann","year":"1999","unstructured":"Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T. & Wanner, C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55, 648\u2013658 (1999).","journal-title":"Kidney Int"},{"key":"18537_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","volume":"62","author":"J Himmelfarb","year":"2002","unstructured":"Himmelfarb, J., Stenvinkel, P., Ikizler, T. A. & Hakim, R. M. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62, 1524\u20131538 (2002).","journal-title":"Kidney Int"},{"key":"18537_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1081\/JDI-100100878","volume":"22","author":"T Takahashi","year":"2000","unstructured":"Takahashi, T., Kubota, M., Nakamura, T., Ebihara, I. & Koide, H. Interleukin-6 gene expression in peripheral mononuclear cells from patients undergoing haemodialysis or continuous ambulatory peritoneal dialysis. Ren Fail 22, 345\u2013354 (2000).","journal-title":"Ren Fail"},{"key":"18537_CR4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1523-1755.2002.kid556.x","volume":"62","author":"K Caglar","year":"2002","unstructured":"Caglar, K. et al. Inflammatory signals associated with hemodialysis. Kidney Int 62, 1408\u20131416 (2002).","journal-title":"Kidney Int"},{"key":"18537_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.ki.5002019","volume":"71","author":"JW Yoon","year":"2007","unstructured":"Yoon, J. W., Pahl, M. V. & Vaziri, N. D. Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int 71, 167\u2013172 (2007).","journal-title":"Kidney Int"},{"key":"18537_CR6","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nm1577","volume":"13","author":"I Ohsawa","year":"2007","unstructured":"Ohsawa, I. et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13, 688\u2013694 (2007).","journal-title":"Nat Med"},{"key":"18537_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13618-015-0035-1","volume":"5","author":"M Ichihara","year":"2015","unstructured":"Ichihara, M. et al. Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles. Med Gas Res 5, 12 (2015).","journal-title":"Med Gas Res"},{"key":"18537_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1542-4758.2007.00187.x","volume":"11","author":"M Nakayama","year":"2007","unstructured":"Nakayama, M. et al. Less-oxidative hemodialysis solution rendered by cathode-side application of electrolyzed water. Hemodial Int 11, 322\u2013327 (2007).","journal-title":"Hemodial Int"},{"key":"18537_CR9","doi-asserted-by":"publisher","first-page":"c9","DOI":"10.1159\/000210569","volume":"15","author":"M Nakayama","year":"2009","unstructured":"Nakayama, M. et al. Biological effects of electrolyzed water in hemodialysis. Nephron Clin Pract 112 15, c9 (2009).","journal-title":"Nephron Clin Pract 112"},{"key":"18537_CR10","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1093\/ndt\/gfq196","volume":"25","author":"M Nakayama","year":"2010","unstructured":"Nakayama, M. et al. A novel bioactive hemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial. Nephrol Dial Transplant 25, 3026\u20133033 (2010).","journal-title":"Nephrol Dial Transplant"},{"key":"18537_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/hdi.12112","volume":"18","author":"H Terawaki","year":"2014","unstructured":"Terawaki, H. et al. Effect of a hydrogen (H2)-enriched solution on the albumin redox of hemodialysis patients. Hemodial Int 18, 459\u2013466 (2014).","journal-title":"Hemodial Int"},{"key":"18537_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1523-1755.2003.00118.x","volume":"64","author":"KC Huang","year":"2003","unstructured":"Huang, K. C., Yang, C. C., Lee, K. T. & Chien, C. T. Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water. Kidney Int 64, 704\u2013714 (2003).","journal-title":"Kidney Int"},{"key":"18537_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ki.5001576","volume":"70","author":"KC Huang","year":"2006","unstructured":"Huang, K. C. et al. Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients. Kidney Int 70, 391\u2013398 (2006).","journal-title":"Kidney Int"},{"key":"18537_CR14","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1093\/ndt\/gfq082","volume":"25","author":"KC Huang","year":"2010","unstructured":"Huang, K. C. et al. Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic hemodialysis. Nephrol Dial Transplant 25, 2730\u20132737 (2010).","journal-title":"Nephrol Dial Transplant"},{"key":"18537_CR15","unstructured":"WHO Collaborating Center for Drug Statistics Methodology. Guidelines for DDD 2nd ed, Oslo, 1\u201395 (1993) ."},{"key":"18537_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/ki.2013.237","volume":"84","author":"J Park","year":"2013","unstructured":"Park, J. et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int 84, 795\u2013802 (2013).","journal-title":"Kidney Int"},{"key":"18537_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/hdi.12156","volume":"18","author":"M Inaba","year":"2014","unstructured":"Inaba, M. et al. Association of blood pressure with all-cause mortality and stroke in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Pattern Study. Hemodial Int 18, 607\u2013615 (2014).","journal-title":"Hemodial Int"},{"key":"18537_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1523-1755.1998.00005.x","volume":"54","author":"PG Zager","year":"1998","unstructured":"Zager, P. G. et al. \u201cU\u201d curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54, 561\u2013569 (1998).","journal-title":"Kidney Int"},{"key":"18537_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s41100-016-0054-y","volume":"2","author":"K Maeda","year":"2016","unstructured":"Maeda, K. et al. Improvement of the fraction of human mercaptalbumin on hemodialysis treatment using hydrogen-dissolved hemodialysis fluid: a prospective observational study. Renal Replacement Therapy 2, 42, https:\/\/doi.org\/10.1186\/s41100-016-0054-y (2016).","journal-title":"Renal Replacement Therapy"},{"key":"18537_CR20","doi-asserted-by":"publisher","first-page":"H1186","DOI":"10.1152\/ajpheart.00283.2015","volume":"309","author":"LV Thang","year":"2015","unstructured":"Thang, L. V. et al. Macrophage depletion lowers blood pressure and restores sympathetic nerve \u03b12-adrenergic receptor function in mesenteric arteries of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 309, H1186\u20131197 (2015).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"18537_CR21","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1113\/jphysiol.2012.228619","volume":"590","author":"VA Averina","year":"2012","unstructured":"Averina, V. A., Othmer, H. G., Fink, G. D. & Osborn, J. W. A new conceptual paradigm for the hemodynamics of salt-sensitive hypertension: a mathematical modelling approach. J Physiol 590, 5975\u20135992 (2012).","journal-title":"J Physiol"},{"key":"18537_CR22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/HYPERTENSIONAHA.112.201251","volume":"60","author":"CT Chan","year":"2012","unstructured":"Chan, C. T. et al. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone\/salt-treated mice. Hypertension 60, 1207\u20131212 (2012).","journal-title":"Hypertension"},{"key":"18537_CR23","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1056\/NEJM197106242842502","volume":"284","author":"MD Levitt","year":"1971","unstructured":"Levitt, M. D. Volume and composition of human intestinal gas determined by means of an intestinal washout technic. N Engl J Med 284, 1394\u20138 (1971).","journal-title":"N Engl J Med"},{"issue":"240\u2013275","key":"18537_CR24","first-page":"2010","volume":"14","author":"Y Tsubakihara","year":"2008","unstructured":"Tsubakihara, Y. et al. Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial 14(240\u2013275), 2010 (2008).","journal-title":"Ther Apher Dial"},{"key":"18537_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa, M. et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17, 247\u2013288 (2013).","journal-title":"Ther Apher Dial"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18537-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:42:54Z","timestamp":1671583374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18537-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["18537"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18537-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"254"}}